Scinai Immunotherapeutics (SCNI) Cash from Operations Growth (1y) (2019 - 2024)
Scinai Immunotherapeutics (SCNI) Cash from Operations Growth (1y) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 60.84% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 85.14% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.72% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 74.39% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Scinai Immunotherapeutics | 3.02 Bn | 988.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.16% |
| Sep 30, 2024 | 8.28% |
| Jun 30, 2024 | 38.87% |
| Mar 31, 2024 | 52.17% |
| Dec 31, 2023 | -106.58% |
| Sep 30, 2023 | -16.82% |
| Jun 30, 2023 | 21.53% |
| Mar 31, 2023 | -176.83% |
| Dec 31, 2022 | 68.17% |
| Sep 30, 2022 | 69.26% |
| Jun 30, 2022 | 53.67% |
| Mar 31, 2022 | 4.74% |
| Dec 31, 2021 | 88.29% |
| Sep 30, 2021 | 40.00% |
| Jun 30, 2021 | 33.19% |
| Mar 31, 2019 | -41.49% |